Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Development of Ribonucleic acid interference (RNAi)- based medicines756.35K100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.K.31.6M97.76%
Germany724.85K2.24%